Skip to main content
ABOS logo

ABOS

Acumen Pharmaceuticals, Inc.
$2.74 +0.15 (+5.79%) At close · Jul 2
Market Cap
$197.90M
Shares
72,227,580

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 85
Total Value: $108,955,506
Total Shares: 46,167,605

Institutional Ownership Trend

19 quarters

Holder Concentration

Across 85 13F filers · Δ vs Dec 31, 2025
Top Holder
45.5%
Jun 2023 → Mar 2026 · range 11.8% – 45.5%
+3.6 pts
Top 5
68.5%
Jun 2023 → Mar 2026 · range 48.0% – 75.1%
+0.3 pts
Top 10
82.2%
Jun 2023 → Mar 2026 · range 73.0% – 90.6%
−0.5 pts
HHI
2,264
Jun 2023 → Mar 2026 · range 642 – 2,264
Moderately concentrated+263

Quarterly Activity

vs Dec 31, 2025
New
21
Increased
31
Decreased
13
Sold Out
7
Unchanged
20
Holder count: +14
Institutional value: +44.7%
Shares held: +29.4%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 89 of 89
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1576885 CUSIP 00509G209 Visit website Investor relations